Industry Update by Dusko Ilic: Capital market and finances

Written by Regenerative Medicine

Latest developments compiled from 1 July until 31 August 2014 Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from non-academic institutions from 1 July until 31 August 2014, scheduled to be published in Volume 9 Issue 6 of Regenerative Medicine. Bellicum Bellicum Pharmaceuticals (TX, USA; www.bellicum.com) successfully completed of a US$ 55 million Series C financing. The funding will be used to expand the clinical evaluation of Bellicum’s stem cell transplant, CAR-T cell and cancer vaccine product candidates in a variety of blood and solid tumor cancers, and...

To view the full article, please register now for access

It's completely free